Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genetron Holdings's share price for the quarter that ended in Jun. 2022 was $5.1. Genetron Holdings's Shares Outstanding (EOP) for the quarter that ended in Jun. 2022 was 30.20 Mil. Therefore, Genetron Holdings's market cap for the quarter that ended in Jun. 2022 was $154.02 Mil.
Genetron Holdings's quarterly market cap
declined
from Dec. 2021 ($552.63 Mil) to Mar. 2022 ($198.42 Mil) and
declined
from Mar. 2022 ($198.42 Mil) to Jun. 2022 ($154.02 Mil).
Genetron Holdings's annual market cap
declined
from Dec. 2020 ($1,237.07 Mil) to Dec. 2021 ($552.63 Mil) and
declined
from Dec. 2021 ($552.63 Mil) to Dec. 2022 ($102.36 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genetron Holdings's Enterprise Value for Today is $127.11 Mil.
Genetron Holdings Market Cap Historical Data
The historical data trend for Genetron Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Genetron Holdings's Market Cap
For the Diagnostics & Research subindustry, Genetron Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genetron Holdings's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genetron Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Genetron Holdings's Market Cap falls into.
Genetron Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Genetron Holdings's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetron Holdings (NAS:GTH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Genetron Holdings Market Cap Related Terms
Thank you for viewing the detailed overview of Genetron Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Genetron Holdings (Genetron Holdings) Business Description
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GTH has been successfully added to your 